ACI
MR

AMP Capital Investors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

AMP Capital Investors’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-42,200
Closed -$1.14M – 1293
2015
Q4 		$1.14M Buy
42,200
+15,400
+57% +$397K 0.01% 817
2015
Q3 		$613K Hold
26,800
– – ﹤0.01% 923
2015
Q2 		$758K Hold
26,800
– – ﹤0.01% 924
2015
Q1 		$733K Hold
26,800
– – ﹤0.01% 952
2014
Q4 		$727K Hold
26,800
– – ﹤0.01% 945
2014
Q3 		$805K Sell
26,800
-27,579
-51% -$854K 0.01% 926
2014
Q2 		$1.74M Sell
54,379
-14,260
-21% -$453K 0.01% 776
2014
Q1 		$2.19M Sell
68,639
-129,000
-65% -$4.52M 0.01% 697
2013
Q4 		$7.17M Sell
197,639
-24,400
-11% -$948K 0.05% 428
2013
Q3 		$8.77M Buy
222,039
+2,400
+1% +$96.7K 0.07% 338
2013
Q2 		$8.35M Buy
+219,639
New +$8.67M 0.06% 329

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AMP Capital Investors's MR Position: Q1 2016 in Review

AMP Capital Investors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 42,200 shares — an estimated $1.14M sold.

AMP Capital Investors first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $8.77M in Q3 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • AMP Capital Investors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • AMP Capital Investors sold 42,200 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1.14M.
  • AMP Capital Investors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • AMP Capital Investors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $8.77M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on AMP Capital Investors's 13F filing for Q1 2016, filed 16 May 2016.